Risk Associated with Cumulative Oral Glucocorticoid Use in Patients with Giant Cell Arteritis in Real-World Databases from the USA and UK.

Gale, Sara; Wilson, Jessica C; Chia, Jenny; Trinh, Huong; Tuckwell, Katie; Collinson, Neil; Dimonaco, Sophie; Jick, Susan; Meier, Christoph; Mohan, Shalini V; Sarsour, Khaled

Gale, Sara; Wilson, Jessica C; Chia, Jenny; Trinh, Huong; Tuckwell, Katie; Collinson, Neil; Dimonaco, Sophie; Jick, Susan; Meier, Christoph; Mohan, Shalini V; Sarsour, Khaled.

Afiliação

Gale S; Genentech, Inc., South San Francisco, CA, USA. gale.sara@gene.com.
Wilson JC; Basel Pharmacoepidemiology Unit, University of Basel, Basel, Switzerland.
Chia J; Genentech, Inc., South San Francisco, CA, USA.
Trinh H; Genentech, Inc., South San Francisco, CA, USA.
Tuckwell K; Genentech, Inc., South San Francisco, CA, USA.
Collinson N; Roche Products, Ltd., Welwyn Garden City, UK.
Dimonaco S; Roche Products, Ltd., Welwyn Garden City, UK.
Jick S; Boston Collaborative Drug Surveillance Program, Boston University School of Public Health, Lexington, MA, USA.
Meier C; Basel Pharmacoepidemiology Unit, University of Basel, Basel, Switzerland.
Mohan SV; Boston Collaborative Drug Surveillance Program, Boston University School of Public Health, Lexington, MA, USA.
Sarsour K; Genentech, Inc., South San Francisco, CA, USA.

Rheumatol Ther ; 5(2): 327-340, 2018 Dec.

Article em En | MEDLINE | ID: mdl-29752705

Palavras-chave

Giant cell arteritis; Glucocorticoid; Safety; Toxicity; Vasculitis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Risk_factors_studies Idioma: En Revista: Rheumatol Ther Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google